<DOC>
	<DOCNO>NCT01928563</DOCNO>
	<brief_summary>This study design investigate pharmacokinetic drug interaction Udenafil Dapoxetine healthy male subject Design : Randomized , open-label , 3-treatment , 6-sequence , 3-period crossover study Investigational Product : Udenafil , Dapoxetine</brief_summary>
	<brief_title>Clinical Trial Investigate Pharmacokinetic Drug Interaction Between Udenafil Dapoxetine</brief_title>
	<detailed_description />
	<mesh_term>Udenafil</mesh_term>
	<criteria>Male volunteer age 20 45 year old screening Body mass index ( BMI ) range 19 27 ㎏/㎡ Sitting position blood pressure meet criteria time screening ( 90mmHg≤Systolic blood pressure≤140mmHg ) History clinically significant disease kidney , liver biliary system , digestive system , respiratory , musculoskeletal , endocrine , neurological psychiatric blood tumor system , cardiovascular system , etc . History gastrointestinal disease gastrointestinal operation might affect study drug absorption Clinically significant hypersensitivity history hypersensitivity reaction Udenafil , Dapoxetine ingredient include element family drug , medication ≥ 1.5 fold normal upper limit ( UNL ) level ALT , AST Alcohol , excessive intake ( &gt; 21 units/week ) Excessive smoker ( &gt; 10 cigarette/day )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>